Literature DB >> 15937179

Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs.

Amit Singh1, Radhika Gupta, R A Vishwakarma, P R Narayanan, C N Paramasivan, V D Ramanathan, Anil K Tyagi.   

Abstract

We had recently reported that the mymA operon (Rv3083 to Rv3089) of Mycobacterium tuberculosis is regulated by AraC/XylS transcriptional regulator VirS (Rv3082c) and is important for the cell envelope of M. tuberculosis. In this study, we further show that a virS mutant (MtbdeltavirS) and a mymA mutant (Mtbmym::hyg) of M. tuberculosis exhibit reduced contents and altered composition of mycolic acids along with the accumulation of saturated C24 and C26 fatty acids compared to the parental strain. These mutants were markedly more susceptible to major antitubercular drugs at acidic pH and also showed increased sensitivity to detergent (sodium dodecyl sulfate) and to acidic stress than the parental strain. We show that disruption of virS and mymA genes impairs the ability of M. tuberculosis to survive in activated macrophages, but not in resting macrophages, suggesting the importance of the mymA operon in protecting the bacterium against harsher conditions. Infection of guinea pigs with MtbdeltavirS, Mtbmym::hyg, and the parental strain resulted in an approximately 800-fold-reduced bacillary load of the mutant strains compared with the parental strain in spleens, but not in the lungs, of animals at 20 weeks postinfection. Phenotypic traits were fully complemented upon reintroduction of the virS gene into MtbdeltavirS. These observations show the important role of the mymA operon in the pathogenesis of M. tuberculosis at later stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937179      PMCID: PMC1151731          DOI: 10.1128/JB.187.12.4173-4186.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  63 in total

Review 1.  The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

Authors:  R A Slayden; C E Barry
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

2.  Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier.

Authors:  L R Camacho; P Constant; C Raynaud; M A Laneelle; J A Triccas; B Gicquel; M Daffe; C Guilhot
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

3.  THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES.

Authors:  D A MITCHISON
Journal:  Bull Int Union Tuberc       Date:  1964-09

4.  The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

Authors:  K Pethe; S Alonso; F Biet; G Delogu; M J Brennan; C Locht; F D Menozzi
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

5.  Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids.

Authors:  L Wang; R A Slayden; C E Barry; J Liu
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

6.  The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages.

Authors:  R Manganelli; M I Voskuil; G K Schoolnik; I Smith
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

7.  Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice.

Authors:  E Dubnau; J Chan; C Raynaud; V P Mohan; M A Lanéelle; K Yu; A Quémard; I Smith; M Daffé
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

8.  A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.

Authors:  M S Glickman; J S Cox; W R Jacobs
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

9.  Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.

Authors:  J D McKinney; K Höner zu Bentrup; E J Muñoz-Elías; A Miczak; B Chen; W T Chan; D Swenson; J C Sacchettini; W R Jacobs; D G Russell
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection.

Authors:  Kaman Chan; Timothy Knaak; Laura Satkamp; Olivier Humbert; Stanley Falkow; Lalita Ramakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

View more
  42 in total

1.  Molecular modeling studies of Fatty acyl-CoA synthetase (FadD13) from Mycobacterium tuberculosis--a potential target for the development of antitubercular drugs.

Authors:  Nidhi Jatana; Sarvesh Jangid; Garima Khare; Anil K Tyagi; Narayanan Latha
Journal:  J Mol Model       Date:  2010-05-08       Impact factor: 1.810

2.  Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.

Authors:  Romain Veyron-Churlet; Isabelle Zanella-Cléon; Martin Cohen-Gonsaud; Virginie Molle; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  Mutational analysis of the -10 region from the Mycobacterium tuberculosis lipF promoter.

Authors:  Michelle Gonzales; Beatrice Saviola
Journal:  Mol Biol Rep       Date:  2008-07-22       Impact factor: 2.316

Review 4.  Antibiotic resistance mechanisms in M. tuberculosis: an update.

Authors:  Liem Nguyen
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

5.  Dissecting the role of critical residues and substrate preference of a Fatty Acyl-CoA Synthetase (FadD13) of Mycobacterium tuberculosis.

Authors:  Garima Khare; Vibha Gupta; Rakesh K Gupta; Radhika Gupta; Rajiv Bhat; Anil K Tyagi
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 6.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

7.  Unraveling the role of the transcriptional regulator VirS in low pH-induced responses of Mycobacterium tuberculosis and identification of VirS inhibitors.

Authors:  Swati Singh; Nikita Goswami; Anil K Tyagi; Garima Khare
Journal:  J Biol Chem       Date:  2019-05-24       Impact factor: 5.157

8.  Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors.

Authors:  Sarah Schmidt Grant; Samantha Wellington; Tomohiko Kawate; Christopher A Desjardins; Melanie R Silvis; Carl Wivagg; Matthew Thompson; Katherine Gordon; Edward Kazyanskaya; Raymond Nietupski; Nathan Haseley; Noriaki Iwase; Ashlee M Earl; Michael Fitzgerald; Deborah T Hung
Journal:  Cell Chem Biol       Date:  2016-06-16       Impact factor: 8.116

9.  A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine.

Authors:  Noton K Dutta; Smriti Mehra; Deepak Kaushal
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

10.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.